AbbVie Inc.ABBVNYSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+41.1%
5Y CAGR+14.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+41.1%/yr
vs +75.4%/yr prior
5Y CAGR
+14.6%/yr
Recent acceleration
Acceleration
-34.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.33% |
| Q3 2025 | -5.46% |
| Q2 2025 | 18.58% |
| Q1 2025 | -12.75% |
| Q4 2024 | 4.47% |
| Q3 2024 | -0.12% |
| Q2 2024 | 24.88% |
| Q1 2024 | -4.43% |
| Q4 2023 | 15.52% |
| Q3 2023 | -22.68% |
| Q2 2023 | 16.82% |
| Q1 2023 | -24.76% |
| Q4 2022 | 11.86% |
| Q3 2022 | -5.98% |
| Q2 2022 | 9.77% |
| Q1 2022 | -10.22% |
| Q4 2021 | 6.17% |
| Q3 2021 | 5.47% |
| Q2 2021 | 7.26% |
| Q1 2021 | -4.11% |
| Q4 2020 | 16.84% |
| Q3 2020 | 16.95% |
| Q2 2020 | 0.55% |
| Q1 2020 | -0.31% |
| Q4 2019 | 2.12% |
| Q3 2019 | 1.91% |
| Q2 2019 | 4.92% |
| Q1 2019 | -2.37% |
| Q4 2018 | -1.84% |
| Q3 2018 | 0.90% |
| Q2 2018 | 5.61% |
| Q1 2018 | 10.04% |
| Q4 2017 | 1.49% |
| Q3 2017 | -0.68% |
| Q2 2017 | 10.04% |
| Q1 2017 | -6.09% |
| Q4 2016 | 6.35% |
| Q3 2016 | -2.36% |
| Q2 2016 | 9.98% |
| Q1 2016 | -6.82% |